Read the latest Oncotarget #announcements and #pressreleases : oncotarget.com/news/pr/ #openaccess #peerreviewed #oncology #cancer #researchpapers

Scientific integrity is a crucial component of scholarly publishing. At Oncotarget, a growing industry of digital technologies, tools and ideas are constantly being added to our robust scientific integrity process: oncotarget.com/scientific_int…

#PaperoftheDay : 'Prevalence and spectrum of germline BRCA1 and BRCA2 in a cohort of ovarian cancer patients from the Salento peninsula (Southern Italy): a matter of preventive health'

DOI ⬇️ doi.org/10.18632/oncot…

Submit a paper online with Oncotarget: oncotarget.msubmit.net/cgi-bin/main.p…

#peerreviewed #journal #openaccess #openscience #publishing #author #research #cancer #oncology #publication

Oncotarget is proud to participate at the Society for Scholarly Publishing (SSP) 46th Annual Meeting convening from May 29–31, 2024, in Boston, Massachusetts.
oncotarget.com/news/pr/oncota…

Learn about Oncotarget’s Editorial Policies and Publishing Standards here: oncotarget.com/editorial-poli…

#publishing #openaccess #policies #standards #journalpublication #peerreviewed #oncology #cancer #research #research papers

Oncotarget.com is a primarily #oncology -focused, #peerreviewed , #openaccess journal. Papers are #published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

#PaperoftheDay : 'GZ17-6.02 interacts with bexarotene to kill mycosis fungoides cells'

DOI ⬇️ doi.org/10.18632/oncot…

SARS-CoV-2 #SpikeProtein Disrupts #p53 Tumor Suppressor Pathway

Blog synopsis of the #newstudy “Transfected SARS-CoV-2 spike DNA for mammalian cell expression inhibits p53 activation of p21(WAF1), TRAIL Death Receptor DR5 and MDM2 proteins in [...]” ⬇️
oncotarget.org/2024/05/09/sar…

Go #BehindTheStudy with Dr. Omkar Desai from Case Western Reserve & University Hospitals as he describes a recent paper: “HER3- A key survival pathway and an emerging therapeutic target in metastatic colorectal cancer and pancreatic ductal adenocarcinoma”

Read, watch, listen ⬇️ oncotarget.net/2023/10/12/beh…

Oncotarget is a contributing sponsor at the International Centre for Genetic Engineering and Biotechnology (ICGEB) 19th International p53 Workshop from May 13–16, 2024, in Trieste, Italy. icgeb.org/p53-conference…

Listen to an #audio version of a #pressrelease about this #research paper recently #published in Volume 15: 'GZ17-6.02 interacts with proteasome inhibitors to kill multiple myeloma cells.'
soundcloud.com/oncotarget/gz1…

#cancer #multiplemeyloma #soundcloud #podcast #openaccess #research

Impact Journals (Oncotarget's publisher) is a supporter and exhibitor of the SSP 46th Annual Meeting from May 29 - 31, 2024, in Boston, MA. customer.sspnet.org/SSP/ssp/AM24/H…

Visit Oncotarget.net for interviews from distinguished Oncotarget authors. #openaccess #peerreviewed #oncology #cancer #researchpapers #science #medicine #medEd #OA

From May 13–16, 2024, Oncotarget will be a contributing sponsor at the 19th International #p53 Workshop in Trieste, Italy. @icgeb #ICGEBmeeting

Learn more: oncotarget.com/news/pr/oncota…

Oncotarget recently #published this #trendingwithimpact editorial in Volume 14: “One more step toward treatment of PARP inhibitor-resistant ovarian cancers.” Mayo Clinic

doi.org/10.18632/oncot…

#cancer #ovariancancer #drugdiscovery #research #oa #oncotargetshort #video

Watch video interviews from outstanding Oncotarget authors: oncotarget.com/videos/intervi…

#PaperoftheDay : 'Combining causal and correlative approaches to discover biomarkers of response to paclitaxel'

DOI: doi.org/10.18632/oncot…

Read Oncotarget’s 2023 publications in Volume 14: oncotarget.com/archive/v14/

#openaccess #publishing #journal #peerreviewed #publication #openscience #oncology #cancer #research #research papers #meded

Visit Oncotarget.org to read blog synopses of new and trending research papers published by Oncotarget. #openaccess #peerreviewed #oncology #cancer #researchpapers #science #medicine #medEd #OA